arrow_back close
News & Events
The EFPIA view
UCB CEO to chair... UCB CEO to chair Innovative Medicines Initiative board
close

UCB CEO to chair Innovative Medicines Initiative board

07.03.12
The Innovative Medicines Initiative (IMI) announced today that Roch Doliveux, CEO of the biopharmaceutical company UCB, has been appointed Chairman of the Governing Board of IMI. IMI is a public-private partnership between the European Union and the European Federation of Pharmaceutical Industries and Associations (EFPIA). UCB has been involved in IMI since its initiation, and Roch Doliveux has been a member of the IMI Governing Board since May 2010.

close
continue